Showing results (31-40 of 103) with videos related to
Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
The Bcl-2 family protein inhibitor, ABT-737, has substantial antimyeloma activity and shows synergistic effect with dexamethasone and melphalanSuzanne Trudel, A Keith Stewart, Zhihua Li, et al.British Journal of Haematology|August 23, 2014
Phase I-II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myelomaDonna E Reece, Esther Masih-Khan, Eshetu G Atenafu, et al.Bioorganic & Medicinal Chemistry|July 2, 2013
A 2,6,9-hetero-trisubstituted purine inhibitor exhibits potent biological effects against multiple myeloma cellsVijay M Shahani, Daniel P Ball, Allan V Ramos, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 1, 2014
Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3 mL per injection sitePamela Ng, Diana Incekol, Roy Lee, et al.Blood Cancer Journal|February 7, 2025
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug developmentPralay Mukhopadhyay, Hesham A Abdullah, Joanna B Opalinska, et al.Clinical Lymphoma, Myeloma & Leukemia|December 23, 2022
Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?Sahar Khan, Donna Reece, Eshetu G Atenafu, et al.Cancer Chemotherapy and Pharmacology|January 29, 2013
An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivoPradip De, Nandini Dey, Breanne Terakedis, et al.Blood|February 10, 2006
The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cellsSuzanne Trudel, A Keith Stewart, Eran Rom, et al.Molecular Pharmacology|January 12, 2011
The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidenceXinliang Mao, Tingjun Hou, Biyin Cao, et al.British Journal of Haematology|November 26, 2013
Autologous stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institutionVictor H Jimenez-Zepeda, Norman Franke, Donna E Reece, et al.Pageof 11